国际肾脏病学会首部转化肾脏病学临床前动物研究共识指南
国际肾脏病学会召开共识会议,汇集全球肾脏病领域专家,针对转化动物研究提出TRANSFORM指南,涵盖疾病模型选择、药代动力学、晚期临床前模型干预、动物选择、统计效能、类器官与器官芯片模型及结果报告等主题,为首部关于肾脏病新药开发中转化动物研究最佳实施的指导文件。
要点
- 首部针对肾脏病新药开发转化动物研究的国际共识指南
- 涵盖疾病模型、药代动力学、晚期临床前干预、动物选择、统计效能、类器官与芯片模型及报告
- 旨在加速肾脏病新药开发,改善患者预后与生活质量
核心结论
- 该共识为首部关于肾脏病新药开发中转化动物研究最佳实施的指导文件。
- 推荐旨在加速肾脏病新药开发,改善多种肾脏病患者的预后与生活质量。
研究设计与样本
- 国际肾脏病学会召开共识会议,汇集全球肾脏病领域专家,制定TRANSFORM指南。
主要发现
- 会议涵盖疾病模型选择、药代动力学、晚期临床前模型干预、动物选择、统计效能、类器官与器官芯片模型及结果报告等主题。
关键数值与推荐
- 原文未报告具体推荐条款与数值。
临床怎么用
- 原文未据此给出具体临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Preclinical tests in animal models are key steps in early drug development. Consequently, the International Society of Nephrology held a consensus meeting that connected experts in the global kidney community in order to provide guidance on optimal management of translational animal studies for the development of new drugs to treat kidney disease, entitled "TRANSFORM; TRAnslational Nephrology Science FOR new Medications." The meeting covered various themes, including the following: (i) selection of disease model; (ii) pharmacokinetics; (iii) interventions in late preclinical models; (iv) choice of animal; (v) statistical power; (vi) organoids and organ-on-a-chip models; and (vii) reporting of results. This guidance is the first to be provided on the optimal conduct of translational animal studies for the development of new drugs to treat kidney disease. These recommendations are designed to accelerate development of new drugs for efficacious treatment of kidney diseases, and to improve the prognosis and quality of life of patients with a variety of kidney diseases.
引用
- Nangaku M, Kitching AR, Boor P, et al. International Society of Nephrology first consensus guidance for preclinical animal studies in translational nephrology. Kidney Int. 2023. PMID: 37001557. doi:10.1016/j.kint.2023.03.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。